Malaysia vs Trinidad and Tobago: HIV-positive TB patients on ART (antiretroviral therapy)
Malaysia
39.0%
in 2024
Trinidad and Tobago
51.0%
in 2024
Malaysia rank
140th
Trinidad and Tobago rank
139th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Malaysia
- Trinidad and Tobago
How they compare
Trinidad and Tobago currently reports 51.0% against 39.0% in Malaysia, a difference of 12.0%.
That makes Trinidad and Tobago's figure about 1.3 times Malaysia's.
The two have swapped places 6 times across 18 shared years of data; in 2007 it was Trinidad and Tobago ahead.
Malaysia ranks 140th and Trinidad and Tobago ranks 139th of 144 countries.
Trinidad and Tobago has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malaysia | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 19.1% | 25.8% | 6.6% | Trinidad and Tobago |
| 2010s | 37.1% | 42.7% | 5.6% | Trinidad and Tobago |
| 2020s | 33.2% | 81.0% | 47.8% | Trinidad and Tobago |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Malaysia or Trinidad and Tobago?
- Trinidad and Tobago, at 51.0% against 39.0% in Malaysia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Malaysia and Trinidad and Tobago?
- 12.0%, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Malaysia and Trinidad and Tobago?
- 18 years are reported by both, from 2007 to 2024.
- How do Malaysia and Trinidad and Tobago rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Malaysia ranks 140th and Trinidad and Tobago ranks 139th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.